Sensus Drug Development Corp., Pharmacia & Upjohn deal

P&U will purchase 19.9 percent of Sensus and may acquire the entire company at a later date. Sensus said the deal was partly driven by its low cash position. Sensus’ pegvisomant growth hormone recept...